middle.news
Neuren Hits Record DAYBUE Sales, Royalty Income Surges 24% in Q3 2025
10:21am on Thursday 6th of November, 2025 AEDT
•
Pharmaceuticals
Read Story
Neuren Hits Record DAYBUE Sales, Royalty Income Surges 24% in Q3 2025
10:21am on Thursday 6th of November, 2025 AEDT
Key Points
Q3 2025 DAYBUE net sales up 11% year-on-year to US$101.1 million
Neuren's Q3 royalty income rises 24% to A$16.4 million
Over 1,000 patients treated with DAYBUE for the first time
74% of new prescriptions from community physicians outside specialist centers
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NEU
OPEN ARTICLE